Trial
NCT04906980
A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Janssen Research & Development, LLC
Collaborators
—
Condition
Dengue
Intervention
JNJ-64281802
Why stopped
Feasibility of enrollment impacted by COVID
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-01